COVID 19 Vaccine Update with Harvard Professor Michael Mina: Safety, Efficacy, Distribution, Trials
•Sep 5, 2020
MedCram - Medical Lectures Explained CLEARLY
Harvard professor and epidemiologist Michael Mina MD, Ph.D. is back on MedCram to give a COVID 19 Vaccine Update including: 00:00 Attention to vaccine safety in phase one, two, and three trials 00:21 Mild side effects from vaccines observed in phase 1 and 2 trials 00:32 Awareness of "fringe effects" when the vaccine is introduced to thousands or millions 00:59 Post-market surveillance of adverse effects vs. coincidence and confounding 01:31 Ensuring efficacy - new territory with a coronavirus vaccine 01:50 Sterilizing immunity 02:06 Relatively weak immune response from coronaviruses vs severity 02:29 Polio and measles vaccines create robust immunity 02:59 New technology being used in some SARS-CoV-2 vaccines 03:47 Cautious optimism about the efficacy of vaccines 04:02 Herd immunity 04:43 Who is going to get the COVID-19 vaccine first? Which countries? 05:15 Medical professionals likely the first to receive vaccines 06:02 Will COVID 19 vaccines block transmission and spread? 06:10 Should kids get the vaccine? 06:37 How well will vaccines work in the elderly and immunocompromised? 07:46 How quickly can the COVID vaccines get distributed? By the end of this year? MedCram has no financial disclosures related to any medical products or vaccines, and from our understanding, Dr. Mina does not either.